semaglutide side effects
Prevention: Follow the reconstitution instructions exactly
6 Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK Correspondence: Konstantinos A Toulis Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece Tel +30 231 038 1902 Email [email protected] *These authors contributed equally to this work Abstract: Glucagon-like peptide 1 receptor agonists (GLP1-RA) are prominent agents in the therapeutics of type 2 diabetes mellitus due to their exemplary efficacy in both preprandial and postprandial glycemia, their safety, low risk of hypoglycemia, their multilevel pathophysiological superiority, weight loss and importantly the observed benefits in cardiovascular disease reduction
however, its selectivity toward GLS1 and failure to inhibit the compensatory effect of GLS2 require in-depth study 14
This method accounted for factors such as age, gender, race, comorbidities, medications, and laboratory data, including HbA1c, blood pressure, lipids, and BMI to provide insights into their roles as risk factors in the outcomes of interest
